Phenolic compounds that cross the blood-brain barrier exert positive health effects as central nervous system antioxidants
- PMID: 34608925
- DOI: 10.1039/d1fo02017j
Phenolic compounds that cross the blood-brain barrier exert positive health effects as central nervous system antioxidants
Abstract
The blood-brain barrier (BBB) is a physical structure whose main function is to strictly regulate access to circulating compounds into the central nervous system (CNS). Vegetable-derived phenolic compounds have been widely studied, with numerous epidemiologic and interventional studies confirming their health-related bioactivities across multiple cells, organs and models. Phenolics are non-essential xenobiotics, and should theoretically be unable to cross the BBB. The present work summarizes current experimental evidence that reveals that not only are phenolic compounds able to cross the BBB and bioaccumulate in the brain, but there is some stereoselectivity, which suggests the presence of specific transporters that allow them to reach the brain. Some molecules cross the BBB intact, while others do so only after being biotransformed or metabolized elsewhere. Once inside the CNS, they prevent or counter oxidative stress, which maintains the molecular, cellular, structural and functional integrity of the brain, and subsequently, overall human health.
Similar articles
-
The source of cerebral insulin.Eur J Pharmacol. 2004 Apr 19;490(1-3):5-12. doi: 10.1016/j.ejphar.2004.02.040. Eur J Pharmacol. 2004. PMID: 15094069 Review.
-
Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?Curr Pharm Des. 2014;20(10):1422-49. doi: 10.2174/13816128113199990463. Curr Pharm Des. 2014. PMID: 23789948 Free PMC article. Review.
-
Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.Drug Metab Dispos. 2010 Aug;38(8):1355-61. doi: 10.1124/dmd.110.033324. Epub 2010 Apr 28. Drug Metab Dispos. 2010. PMID: 20427691
-
Brain meets body: the blood-brain barrier as an endocrine interface.Endocrinology. 2012 Sep;153(9):4111-9. doi: 10.1210/en.2012-1435. Epub 2012 Jul 9. Endocrinology. 2012. PMID: 22778219 Free PMC article. Review.
-
In Vivo Evaluation of BBB Integrity in the Post-stroke Brain.Methods Mol Biol. 2023;2616:191-203. doi: 10.1007/978-1-0716-2926-0_15. Methods Mol Biol. 2023. PMID: 36715936 Free PMC article.
Cited by
-
The Neuroprotective Effects of Curcumin Nanoparticles on The Cerebral Ischemia-Reperfusion Injury in The Rats-The Roles of The Protein Kinase RNA-Like ER Kinase/Extracellular Signal-Regulated Kinase and Transcription Factor EB proteins.Cell J. 2024 Jan 31;26(1):62-69. doi: 10.22074/cellj.2023.1995696.1257. Cell J. 2024. PMID: 38351730 Free PMC article.
-
Phenols and GABAA receptors: from structure and molecular mechanisms action to neuropsychiatric sequelae.Front Pharmacol. 2024 Jan 18;15:1272534. doi: 10.3389/fphar.2024.1272534. eCollection 2024. Front Pharmacol. 2024. PMID: 38303988 Free PMC article. Review.
-
Ginkgo biloba: Antioxidant Activity and In Silico Central Nervous System Potential.Curr Issues Mol Biol. 2023 Dec 1;45(12):9674-9691. doi: 10.3390/cimb45120604. Curr Issues Mol Biol. 2023. PMID: 38132450 Free PMC article.
-
Neuroprotective Agents with Therapeutic Potential for COVID-19.Biomolecules. 2023 Oct 27;13(11):1585. doi: 10.3390/biom13111585. Biomolecules. 2023. PMID: 38002267 Free PMC article. Review.
-
4-Ethylphenol-fluxes, metabolism and excretion of a gut microbiome derived neuromodulator implicated in autism.Front Mol Biosci. 2023 Oct 12;10:1267754. doi: 10.3389/fmolb.2023.1267754. eCollection 2023. Front Mol Biosci. 2023. PMID: 37900921 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
